All trading involves risk. Contracts for Difference (CFDs) are complex instruments and may not be suitable for all investors. Please refer to Risk Disclosure and Risk Fact Sheet on Capital.com/en-sg.
Open platformOpen platform

Canada's PyroGenesis Q3 revenue falls as biogas, SPARC sales drop

By Reuters News


Overview

  • Canada plasma tech firm's Q3 revenue fell 5% yr/yr to C$3.07 mln

  • Gross margin for Q3 rose to 35% from 24% a year earlier

  • Company completed acquisition of 50% stake in HPQ Silica Polvere Inc.


Outlook

  • Company is not providing specific revenue or net income guidance for 2026


Result Drivers

  • BIOGAS AND POLLUTION CONTROLS - Revenue from biogas upgrading and pollution controls fell by C$1.0 mln due to fewer project phases compared to Q3 2025

  • TORCH-RELATED SALES - Torch-related products and services revenue rose by C$0.5 mln, reflecting continued execution of plasma torch contracts

  • SPARC SALES DECLINE - SPARC-related sales dropped by C$0.3 mln as significant delivery and commissioning activities occurred earlier in the year


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

C$3.07 mln

Q3 Gross Margin

35.00%


Reuters Recommended Reads

  • Nov 12 - Canada's Mattr Q3 revenue rises 34% on Composite Technologies demand

  • Nov 12 - Canada's Exchange Income Q3 revenue up on aerospace & aviation, manufacturing growth

  • Nov 12 - Canada's Martinrea Q3 results beat estimates on operating improvements


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.